UCB Announces U.S. Availability Of BIMZELX To Treat Adults With Moderate-to-Severe Plaque Psoriasis

RTTNews | hace 622
Stocktwits
UCB Announces U.S. Availability Of BIMZELX To Treat Adults With Moderate-to-Severe Plaque Psoriasis

(RTTNews) - Biopharmaceutical company UCB (UCB) announced Tuesday the commercial availability of BIMZELX in the United States for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

BIMZELX was approved by the U.S. Food and Drug Administration (FDA) on October 17, 2023. It is the first and only IL-17A and IL-17F inhibitor approved for the treatment of adults with moderate-to-severe plaque psoriasis.

BIMZELX is available as an autoinjector and a pre-filled syringe and it may be administered subcutaneously by a healthcare professional, or a patient may self-inject after proper training.

BIMZELX is the first and only approved psoriasis treatment designed to selectively inhibit two key cytokines driving inflammatory processes - interleukin 17A (IL-17A) and interleukin 17F (IL-17F).

The approval of BIMZELX is supported by data from three Phase 3, multicenter, randomized, placebo and/or active comparator-controlled trials (BE READY, BE VIVID, and BE SURE), which evaluated the efficacy and safety of BIMZELX in 1,480 adults with moderate-to-severe plaque psoriasis.

Tags: UCB
Stocktwits
read more
U.S. Dollar Extends Gain Against Majors

U.S. Dollar Extends Gain Against Majors

The U.S. dollar extended gains against its major counterparts in the New York session on Monday, as investors cheered the US-EU trade deal.
RTTNews | hace 54 minutos
Swiss Stocks Slip On Late Selling; SMI Ends 0.34% Down

Swiss Stocks Slip On Late Selling; SMI Ends 0.34% Down

The Switzerland market closed weak on Monday as a few stocks tumbled on selling pressure in the final hour of the day's session. The market got off to a firm start, in line with markets across Europe, as news about the U.S. and European Union agreed on a trade deal over the weekend. However, the mood turned cautious as the day progressed, and the market eventually closed on a weak note.
RTTNews | hace 4h 33min
European Markets Fail To Hold Gains, Settle Weak

European Markets Fail To Hold Gains, Settle Weak

Despite opening on a bright note, European stocks retreated and settled mostly lower on Monday, as initial buoyancy over an EU-US trade deal faded and investors looked ahead to earnings updates, some crucial economic data and policy announcements from the Federal Reserve and the Bank of Japan this week.
RTTNews | hace 4h 59min
Canadian Market Modestly Lower; Materials Stocks Decline

Canadian Market Modestly Lower; Materials Stocks Decline

Despite the U.S.-European Union agreeing on a trade deal over the weekend, the mood in the market remains cautious. The market slipped after opening flat Monday morning, and despite staging a recovery subsequently, remains in negative territory, weighed down by losses in materials sector due to weak metal prices.
RTTNews | hace 6h 12min
Tesla, Samsung Sign $16.54 Bln Chip Deal; Shares Gain

Tesla, Samsung Sign $16.54 Bln Chip Deal; Shares Gain

EV major Tesla Inc. and South Korean chip maker Samsung Electronics Co. Ltd. have entered into a contract worth around 22.76 trillion Korean Won or $16.54 billion for semiconductor contract manufacturing. Tesla founder and CEO Elon Musk in a post on the social media platform confirmed that Samsung will be making Tesla's next-generation AI6 chip.
RTTNews | hace 8h 22min
Bay Street Likely To Open Higher

Bay Street Likely To Open Higher

Canadian shares may open on a positive note Monday morning following the U.S. and European Union agreeing on a trade deal.
RTTNews | hace 9h 39min
Herramientas
Calendario económico
Horario del mercado
Tasas de interés
Calendario de festivos
Mercados Forex
Volatilidad Forex
Correlación Forex
Noticias del Forex
forex analysis
Datos COT
Liquidez
Calculadoras Forex
Heat Map del Forex
Mapa de calor de indicadores
Comunidad
Comunidad
Sistemas
Sistemas más populares
Estrategias
Concursos
Gráficos Forex
Sentimiento Forex
Indicador de perspectivas
Revisiones
Corredores
Prop Trading Firms
Servicios SPV
Proveedor de señales
Servicios de programación de AE
Affiliate Programs
Servicios de corretaje PAMM
Servicios de programas de rebaja
Plataformas de trading
Asesores Expertos
Exchanges de Criptomonedas
Trading Courses
Corredores
Spreads de Forex
Cotizaciones de los corredores de Forex
Swaps de corredores de Forex
Volumen del corredor Forex
Promociones de corredores Forex Comunicado De Prensa
Plataforma
Widgets
Funciones
API
RSS
Stock Portfolio
Affiliate Software
Gráficos avanzados
Soporte
FAQ
Ayuda
Póngase en contacto con nosotros
¡Informar de un error!
Acerca de
Blog
© 2025 Myfxbook Ltd. Todos los Derechos Reservados.
ADVERTENCIA DE ALTO RIESGO: El comercio de divisas implica un alto nivel de riesgo que puede no ser adecuado para todos los inversores. El efecto de apalancamiento crea un riesgo adicional y una exposición a las pérdidas. Antes de decidirse a operar con divisas, considere cuidadosamente sus objetivos de inversión, su nivel de experiencia y su tolerancia al riesgo. Podría perder una parte o la totalidad de su inversión inicial. No invierta dinero que no puede permitirse perder. Infórmese sobre los riesgos asociados al trading de divisas y pida consejo a un asesor financiero o fiscal independiente si tiene alguna duda. Todos los datos y la información se proporcionan "tal cual" con fines informativos únicamente y no están destinados a fines comerciales o de recomendación. Los resultados pasados no son indicativos de los resultados futuros.